5 Results for "

pyrazolopyrimidine compound

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "pyrazolopyrimidine compound" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-10520
CAS No.: 522629-08-9
Purity:  98.71%
Target:  

MNK Apoptosis

Research Areas:  

Cancer

CGP 57380 is a cell-permeable pyrazolo-pyrimidine compound that acts as a selective inhibitor of Mnk1 with IC50 of 2.2 μM, but has no inhibitory activity against p38, JNK1, ERK1/2, PKC, or Src-like kinases.
loading...
    loading...
Cat. No.: HY-153246
CAS No.: 2414149-20-3
Research Areas:  

Cancer

ALK2-IN-5, pyrazolopyrimidine compound, is an ALK2 inhibitor. ALK2-IN-5 can inhibit ALK2 activity and FGFR activity. ALK2-IN-5 can be used for the research of disorders associated with ALK2 activity and/or FGFR activity, such as cancer .
loading...
    loading...
Cat. No.: HY-117882
CAS No.: 147676-50-4
Synonyms: Piperidino-acetildenafil
Target:  

Drug Intermediate

Research Areas:  

Others

Piperiacetildenafil (compound 3) is an intermediate for the preparation of pyrazolopyrimidines .
loading...
    loading...
Cat. No.: HY-157487
Target:  

Drug Derivative

Research Areas:  

Cancer

Anticancer agent 185 (compound 9d) is a glycohybrid derivative of pyrazolopyrimidine [1,5-a]. Anticancer agent 185 has good anti-breast cancer activity. Anticancer agent 185 shows good cytotoxic activity against MCF-7 cells with IC50 value of 15.3 μM .
loading...
    loading...
Cat. No.: HY-10520R
CAS No.: 522629-08-9
Research Areas:  

Cancer

CGP 57380 (Standard) is the analytical standard of CGP 57380 (HY-10520). This product is intended for research and analytical applications. CGP 57380 is a cell-permeable pyrazolo-pyrimidine compound that acts as a selective inhibitor of Mnk1 with IC50 of 2.2 μM, but has no inhibitory activity against p38, JNK1, ERK1/2, PKC, or Src-like kinases.
loading...
    loading...